Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,568,974 papers from all fields of science
Search
Sign In
Create Free Account
Unresectable Esophageal Carcinoma
Known as:
Unresectable Esophageal Cancer
, Esophageal Carcinoma Unresectable
, Unresectable Cancer of Esophagus
Expand
A carcinoma that arises from the esophagus and is not amenable to surgical resection.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Epithelial Cells
Epithelium
Epithelium of esophagus
Esophagus
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Combined hepatectomy and radiofrequency ablation versus TACE in improving survival of patients with unresectable BCLC stage B HCC.
Yi-fu Hou
,
Yonggang Wei
,
+4 authors
Bo Li
Hepatobiliary & Pancreatic Diseases International
2016
Corpus ID: 19247376
Highly Cited
2010
Highly Cited
2010
FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma
T. Higashi
,
E. Hatano
,
+10 authors
S. Kamimoto
European Journal of Nuclear Medicine and…
2010
Corpus ID: 1235248
PurposeTo elucidate the prognostic role of post-therapeutic 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET…
Expand
2009
2009
A Prospective, Multicenter, Phase 2 Study of Imatinib Mesylate in Korean Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumor
M. Ryu
,
W. Kang
,
+15 authors
Yoon-Koo Kang
Oncology
2009
Corpus ID: 21806380
Objectives: This prospective, multicenter, phase 2 study evaluated the efficacy and safety of imatinib mesylate and assessed KIT…
Expand
2009
2009
Surgical radiofrequency ablation for treatment of hepatocellular carcinoma: an endoscopic or open approach.
Shinji Tanaka
,
M. Shimada
,
+6 authors
Y. Maehara
Hepato-Gastroenterology
2009
Corpus ID: 33166567
Radiofrequency ablation (RFA) is widely used for the treatment of unresectable hepatocellular carcinoma (HCC) with cirrhosis…
Expand
2008
2008
Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer.
F. Banki
,
Wael N. Yacoub
,
+7 authors
T. Demeester
Journal of the American College of Surgeons
2008
Corpus ID: 35630799
Review
2008
Review
2008
Hepatocellular carcinoma in viral hepatitis: improving standard therapy.
Ryota Masuzaki
,
H. Yoshida
,
R. Tateishi
,
S. Shiina
,
M. Omata
Best practice & research. Clinical…
2008
Corpus ID: 11578513
Highly Cited
2000
Highly Cited
2000
Evaluation of combined therapy with chemoembolization and irradiation for large hepatocellular carcinoma.
W J Guo
,
E. Yu
British Journal of Radiology
2000
Corpus ID: 28878397
The effects of combined transcatheter arterial chemoembolization (TACE) and radiotherapy in patients with large hepatocellular…
Expand
1991
1991
Cytoreduction and sequential resection: A hope for unresectable primary liver cancer
Zhao-You Tang
,
Yeqin Yu
,
+8 authors
M. Zhang
Journal of Surgical Oncology
1991
Corpus ID: 85828
For decades, unresectable primary liver cancer (PLC) determined by operation was incurable. However, a retrospective study of 24…
Expand
1988
1988
Heat, drugs, and radiation given in combination is palliative for unresectable esophageal cancer.
H. Kai
,
H. Matsufuji
,
Y. Okudaira
,
K. Sugimachi
International Journal of Radiation Oncology…
1988
Corpus ID: 6235719
1978
1978
Histopathologic findings after cis-platinum bleomycin therapy in advanced previously untreated head and neck carcinoma.
S. Shapshay
,
W. Hong
,
+4 authors
M. Strong
American Journal of Surgery
1978
Corpus ID: 46410076
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE